Clinical trial · Interventional
A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia
NCT02619604CI-TRIAL-00025981Med-IQ CLLcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project addresses the need to improve physician knowledge and clinical practice patterns related to quality of life (QoL) concerns for patients with chronic lymphocytic leukemia (CLL).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Lymphocytic Leukemia | Chronic Lymphocytic Leukemia | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Education Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Clinician education
- interventionNames
- Other: Education Intervention
Primary outcomes (2)
- measure
- Change in provider knowledge with management of Quality of Life Concerns for CLL patients, as measured by survey
- timeFrame
- Baseline, 6 months
- measure
- Change in provider confidence with management of Quality of Life Concerns for CLL patients, as measured by survey
- timeFrame
- Baseline, 6 months
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: Clinician * Participant must be a hematologist, oncologist, nurse practitioner, or physician assistant who practices medicine in the Duke Cancer Network * Participant treats patients with CLL * Participant is willing to participate in the educational component of this project Inclusion Criteria: Patient * Patient has a diagnosis of Chronic Lymphocytic Leukemia * Patient is over the age of 18 * Patient is being treated at a Duke Cancer Network affiliate site, * Patient is expected to see their physician or another member of their care team at least 3 times annually. * Signed informed consent Exclusion Criteria: Clinician * None Exclusion Criteria: Patient * Patient is Non-English speaking * Patient diagnosed with CLL \< 60 days ago
References
Publications (0)
Data not yet available
No reference posted for this study.